Literature DB >> 8904890

Stem cell mobilization in normal donors for allogeneic transplantation: analysis of safety and factors affecting efficacy.

G Miflin1, C Charley, C Stainer, S Anderson, A Hunter, N Russell.   

Abstract

The use of peripheral blood stem cells instead of bone marrow as the source of haemopoietic cells for allogeneic transplantation is being increasingly explored. We have analysed data from 17 normal donors who underwent stem cell mobilization for allogeneic transplantation with an identical protocol using G-CSF at a dose of 10 micrograms/kg/d, with the first leukapheresis (LP) on the day following the fourth dose of G-CSF. Both G-CSF administration and leukapheresis were well tolerated. Donors under-went a median of two leukaphereses (range one to three) and a median of 6.80 x 10(6) CD34+ cells/kg recipient weight (range 2.4-15.6 x 10(6)) were collected. The median number of CD34+ cells per kg donor weight was 6.05 x 10(6), when corrected for a 12 litre leukapheresis, this gave a median total of 3.89 x 10(6) CD34+ cells/kg donor weight. When analysed with respect to factors which might influence the efficacy of mobilization, male donors were associated with a superior yield. The median number of CD34+ cells/kg/LP harvested was 4.96 x 10(6) in males and 2.79 x 10(6) in females (P < 0.05). The results suggested that, given a recipient of 75 kg, in a male donor a single 12 litre leukapheresis should yield sufficient CD34+ cells (4 x 10(6)/ kg), whereas a female donor would be likely to need two leukaphereses. Age was not found to affect donor yield. In summary, these data confirm that leukapheresis is a safe procedure in normal donors and suggest that males may be more efficient mobilizers of stem cells than females.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8904890     DOI: 10.1046/j.1365-2141.1996.d01-1897.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  6 in total

Review 1.  G-CSF-primed bone marrow as a source of stem cells for allografting: revisiting the concept.

Authors:  U Deotare; G Al-Dawsari; S Couban; J H Lipton
Journal:  Bone Marrow Transplant       Date:  2015-04-27       Impact factor: 5.483

Review 2.  A review of the haematopoietic stem cell donation experience: is there room for improvement?

Authors:  A Billen; J A Madrigal; B E Shaw
Journal:  Bone Marrow Transplant       Date:  2014-01-27       Impact factor: 5.483

3.  Stem cell collection in unmanipulated HLA-haploidentical/mismatched related transplantation with combined granulocyte-colony stimulating factor-mobilised blood and bone marrow for patients with haematologic malignancies: the impact of donor characteristics and procedural settings.

Authors:  C Zhang; X-H Chen; X Zhang; L Gao; L Gao; P-Y Kong; X-G Peng; A-H Sun; Y Gong; D-F Zeng; Q-Y Wang
Journal:  Transfus Med       Date:  2010-02-01       Impact factor: 2.019

4.  Race and ethnicity influences collection of granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells from unrelated donors, a Center for International Blood and Marrow Transplant Research analysis.

Authors:  Jack W Hsu; John R Wingard; Brent R Logan; Pintip Chitphakdithai; Gorgun Akpek; Paolo Anderlini; Andrew S Artz; Chris Bredeson; Steven Goldstein; Gregory Hale; Peiman Hematti; Sarita Joshi; Rammurti T Kamble; Hillard M Lazarus; Paul V O'Donnell; Michael A Pulsipher; Bipin N Savani; Raquel M Schears; Bronwen E Shaw; Dennis L Confer
Journal:  Biol Blood Marrow Transplant       Date:  2014-10-12       Impact factor: 5.742

5.  Donor demographic and laboratory predictors of allogeneic peripheral blood stem cell mobilization in an ethnically diverse population.

Authors:  Sumithira Vasu; Susan F Leitman; John F Tisdale; Matthew M Hsieh; Richard W Childs; A John Barrett; Daniel H Fowler; Michael R Bishop; Elizabeth M Kang; Harry L Malech; Cynthia E Dunbar; Hanh M Khuu; Robert Wesley; Yu Y Yau; Charles D Bolan
Journal:  Blood       Date:  2008-06-03       Impact factor: 22.113

Review 6.  Toward personalized cell therapies by using stem cells: seven relevant topics for safety and success in stem cell therapy.

Authors:  Fernando de Sá Silva; Paula Nascimento Almeida; João Vitor Paes Rettore; Claudinéia Pereira Maranduba; Camila Maurmann de Souza; Gustavo Torres de Souza; Rafaella de Souza Salomão Zanette; Sueli Patricia Harumi Miyagi; Marcelo de Oliveira Santos; Márcia Martins Marques; Carlos Magno da Costa Maranduba
Journal:  J Biomed Biotechnol       Date:  2012-11-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.